skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta)

Clinical infectious diseases, 2022-08, Vol.75 (1), p.e1128-e1136 [Peer Reviewed Journal]

The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. 2021 ;The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciab721 ;PMID: 34423834

Full text available

Citations Cited by
  • Title:
    Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta)
  • Author: Ong, Sean Wei Xiang ; Chiew, Calvin J ; Ang, Li Wei ; Mak, Tze Minn ; Cui, Lin ; Toh, Matthias Paul H S ; Lim, Yi Ding ; Lee, Pei Hua ; Lee, Tau Hong ; Chia, Po Ying ; Maurer-Stroh, Sebastian ; Lin, Raymond T P ; Leo, Yee Sin ; Lee, Vernon J ; Lye, David Chien ; Young, Barnaby Edward
  • Subjects: Cohort Studies ; COVID-19 - epidemiology ; Humans ; Major ; Retrospective Studies ; SARS-CoV-2 - genetics
  • Is Part Of: Clinical infectious diseases, 2022-08, Vol.75 (1), p.e1128-e1136
  • Description: Abstract Background The impact of SARS-CoV-2 variants of concern (VOCs) on disease severity is unclear. In this retrospective study, we compared the outcomes of patients infected with B.1.1.7, B.1.351, and B.1.617.2 with wild-type strains from early 2020. Methods National surveillance data from January to May 2021 were obtained and outcomes in relation to VOCs were explored. Detailed patient-level data from all patients with VOC infection admitted to our center between December 2020 and May 2021 were analyzed. Clinical outcomes were compared with a cohort of 846 patients admitted from January to April 2020. Results A total of 829 patients in Singapore in the study period were infected with these 3 VOCs. After adjusting for age and sex, B.1.617.2 was associated with higher odds of oxygen requirement, intensive care unit admission, or death (adjusted odds ratio [aOR], 4.90; 95% confidence interval [CI]: 1.43-30.78). Of these patients, 157 were admitted to our center. After adjusting for age, sex, comorbidities, and vaccination, the aOR for pneumonia with B.1.617.2 was 1.88 (95% CI: .95-3.76) compared with wild-type. These differences were not seen with B.1.1.7 and B.1.351. Vaccination status was associated with decreased severity. B.1.617.2 was associated with significantly lower polymerase chain reaction cycle threshold (Ct) values and longer duration of Ct value ≤30 (median duration 18 days for B.1.617.2, 13 days for wild-type). Conclusions B.1.617.2 was associated with increased severity of illness, and with lower Ct values and longer viral shedding. These findings provide impetus for the rapid implementation of vaccination programs. In this retrospective cohort study we found an association between infection with B.1.617.2 (Delta) and increased disease severity. B.1.617.2 was also associated with higher viral loads and prolonged duration of viral shedding. Vaccination remained protective.
  • Publisher: US: Oxford University Press
  • Language: English
  • Identifier: ISSN: 1058-4838
    EISSN: 1537-6591
    DOI: 10.1093/cid/ciab721
    PMID: 34423834
  • Source: Oxford Open (Open Access)
    MEDLINE
    Alma/SFX Local Collection

Searching Remote Databases, Please Wait